PAINREFORM LTD.
Specialty pharma developing extended-release drugs for post-operative pain management.
PRFX | US
Overview
Corporate Details
- ISIN(s):
- IL0011651580
- LEI:
- Country:
- United States of America
- Address:
- 65 YIGAL ALON ST., 6744316 TEL AVIV
- Website:
- https://painreform.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
PainReform Ltd. is a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics for improved pain management. The company develops treatments using its proprietary extended-release drug-delivery system, designed to prolong efficacy, reduce adverse effects, and increase patient comfort. Its lead product candidate, PRF-110, is an oil-based solution that is instilled directly into a surgical wound to provide localized and extended post-operative analgesia. This approach aims to reduce the need for systemically administered opiates. The company is also strategically expanding its drug delivery platform into other therapeutic areas, such as ophthalmology.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all PAINREFORM LTD. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PAINREFORM LTD.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PAINREFORM LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
